According to a recent study, Preterax, a high blood-pressure drug developed by French drugmaker Servier, can reduce the risk of death, as well as the risks of heart and kidney disease.
Preterax was tested against a placebo with the following results.
Researchers found that in patients taking Preterax the risk of heart attack, stroke and degenerative eye disease was reduced by 9%.
The relative risk of death from cardiovascular disease was reduced by 18%, and death from any cause was reduced by 14%.
Many studies have shown that high blood pressure is linked to complications associated with diabetes, such as heart attack, stroke and damage to blood vessels in the eyes and kidneys. Guidelines for physicians recommend intensively lowering blood pressure in diabetic patients. The study's authors suggested that giving Preterax to half of all diabetics could cut deaths by 1 million a year.
The study tracked over 11,000 people with type-2 diabetes from 215 medical centers in 20 countries around the world. The doctors could give patients taking placebo additional medicines including cholesterol-lowering drugs and anti-platelet therapy to prevent clotting.